nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0299	0.116	CbGpPWpGaD
Codeine—CYP3A4—urine—nephrolithiasis	0.0217	0.0961	CbGeAlD
Codeine—CYP2D6—urine—nephrolithiasis	0.0214	0.0946	CbGeAlD
Codeine—UGT2B4—Phase II conjugation—SLC26A1—nephrolithiasis	0.0208	0.0804	CbGpPWpGaD
Codeine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0389	CcSEcCtD
Codeine—UGT2B7—renal system—nephrolithiasis	0.0195	0.0863	CbGeAlD
Codeine—OPRD1—renal system—nephrolithiasis	0.0191	0.0846	CbGeAlD
Codeine—UGT2B7—kidney—nephrolithiasis	0.0189	0.0834	CbGeAlD
Codeine—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.0188	0.0833	CbGeAlD
Codeine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0361	CcSEcCtD
Codeine—OPRD1—kidney—nephrolithiasis	0.0185	0.0818	CbGeAlD
Codeine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0336	CcSEcCtD
Codeine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0324	CcSEcCtD
Codeine—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.0161	0.0713	CbGeAlD
Codeine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0312	CcSEcCtD
Codeine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0309	CcSEcCtD
Codeine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0308	CcSEcCtD
Codeine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0149	0.029	CcSEcCtD
Codeine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.013	0.0252	CcSEcCtD
Codeine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0241	CcSEcCtD
Codeine—UGT2B4—Biological oxidations—SLC26A1—nephrolithiasis	0.0121	0.047	CbGpPWpGaD
Codeine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0228	CcSEcCtD
Codeine—SLC22A1—renal system—nephrolithiasis	0.0117	0.0516	CbGeAlD
Codeine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0219	CcSEcCtD
Codeine—SLC22A1—kidney—nephrolithiasis	0.0113	0.0499	CbGeAlD
Codeine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0206	CcSEcCtD
Codeine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0202	CcSEcCtD
Codeine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0103	0.02	CcSEcCtD
Codeine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0198	CcSEcCtD
Codeine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00995	0.0193	CcSEcCtD
Codeine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0191	CcSEcCtD
Codeine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00975	0.0189	CcSEcCtD
Codeine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0188	CcSEcCtD
Codeine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00957	0.0186	CcSEcCtD
Codeine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00954	0.0185	CcSEcCtD
Codeine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00952	0.0185	CcSEcCtD
Codeine—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00945	0.0366	CbGpPWpGaD
Codeine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00938	0.0182	CcSEcCtD
Codeine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00933	0.0181	CcSEcCtD
Codeine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0175	CcSEcCtD
Codeine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00893	0.0173	CcSEcCtD
Codeine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0171	CcSEcCtD
Codeine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0169	CcSEcCtD
Codeine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0165	CcSEcCtD
Codeine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00846	0.0164	CcSEcCtD
Codeine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00837	0.0162	CcSEcCtD
Codeine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00826	0.016	CcSEcCtD
Codeine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0081	0.0157	CcSEcCtD
Codeine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00784	0.0152	CcSEcCtD
Codeine—CYP3A5—nephron tubule—nephrolithiasis	0.00779	0.0345	CbGeAlD
Codeine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00772	0.015	CcSEcCtD
Codeine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0149	CcSEcCtD
Codeine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0146	CcSEcCtD
Codeine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00747	0.0145	CcSEcCtD
Codeine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0144	CcSEcCtD
Codeine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0138	CcSEcCtD
Codeine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00708	0.0137	CcSEcCtD
Codeine—CYP3A5—renal system—nephrolithiasis	0.00708	0.0313	CbGeAlD
Codeine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0133	CcSEcCtD
Codeine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00685	0.0133	CcSEcCtD
Codeine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00685	0.0133	CcSEcCtD
Codeine—CYP3A5—kidney—nephrolithiasis	0.00685	0.0303	CbGeAlD
Codeine—CYP3A5—cortex of kidney—nephrolithiasis	0.00667	0.0295	CbGeAlD
Codeine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00638	0.0124	CcSEcCtD
Codeine—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00631	0.0244	CbGpPWpGaD
Codeine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00622	0.012	CcSEcCtD
Codeine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0119	CcSEcCtD
Codeine—OPRD1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0061	0.0236	CbGpPWpGaD
Codeine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00598	0.0232	CbGpPWpGaD
Codeine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00573	0.0111	CcSEcCtD
Codeine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00556	0.0215	CbGpPWpGaD
Codeine—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00553	0.0214	CbGpPWpGaD
Codeine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00551	0.0107	CcSEcCtD
Codeine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0106	CcSEcCtD
Codeine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0106	CcSEcCtD
Codeine—OPRK1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00535	0.0207	CbGpPWpGaD
Codeine—CYP3A4—renal system—nephrolithiasis	0.00531	0.0235	CbGeAlD
Codeine—CYP2D6—renal system—nephrolithiasis	0.00523	0.0231	CbGeAlD
Codeine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00997	CcSEcCtD
Codeine—CYP3A4—kidney—nephrolithiasis	0.00514	0.0227	CbGeAlD
Codeine—CYP2D6—kidney—nephrolithiasis	0.00506	0.0224	CbGeAlD
Codeine—OPRM1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00452	0.0175	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00392	0.0152	CbGpPWpGaD
Codeine—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00378	0.0146	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00359	0.0139	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00359	0.0139	CbGpPWpGaD
Codeine—OPRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00276	0.0107	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—GRHPR—nephrolithiasis	0.00274	0.0106	CbGpPWpGaD
Codeine—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00273	0.0106	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00272	0.0105	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00272	0.0105	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00253	0.00979	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00253	0.00979	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—AGXT—nephrolithiasis	0.00244	0.00946	CbGpPWpGaD
Codeine—OPRK1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00242	0.00939	CbGpPWpGaD
Codeine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00237	0.00917	CbGpPWpGaD
Codeine—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00225	0.00873	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00224	0.00866	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00224	0.00866	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00209	0.00808	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—APRT—nephrolithiasis	0.00208	0.00805	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—SLC26A1—nephrolithiasis	0.00208	0.00805	CbGpPWpGaD
Codeine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00208	0.00804	CbGpPWpGaD
Codeine—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00205	0.00793	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00199	0.00772	CbGpPWpGaD
Codeine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00194	0.00753	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00189	0.00734	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00183	0.00709	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00182	0.00706	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00182	0.00706	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.0018	0.00698	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00175	0.0068	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—RGS14—nephrolithiasis	0.00166	0.00644	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00165	0.00639	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00158	0.00612	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00155	0.00599	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—AQP1—nephrolithiasis	0.00148	0.00573	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—PTH—nephrolithiasis	0.00145	0.0056	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00141	0.00546	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.0014	0.00544	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00138	0.00535	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00138	0.00535	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—CHRM3—nephrolithiasis	0.00134	0.00518	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00134	0.00518	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.00132	0.0051	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00128	0.00498	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00128	0.00498	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00128	0.00496	CbGpPWpGaD
Codeine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00127	0.00492	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.00125	0.00484	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00124	0.00479	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00122	0.00473	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.00115	0.00447	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00114	0.00444	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00114	0.00444	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—DGKH—nephrolithiasis	0.00112	0.00435	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—RGS14—nephrolithiasis	0.00112	0.00434	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.00111	0.00431	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00104	0.00405	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00102	0.00395	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000981	0.0038	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000975	0.00378	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000948	0.00367	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000946	0.00366	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000946	0.00366	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000932	0.00361	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000925	0.00358	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000915	0.00355	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000893	0.00346	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000853	0.0033	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—PTH—nephrolithiasis	0.000846	0.00328	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000829	0.00321	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—PTH—nephrolithiasis	0.000817	0.00317	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000811	0.00314	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000794	0.00308	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.00076	0.00295	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000756	0.00293	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000756	0.00293	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000755	0.00292	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—PTH—nephrolithiasis	0.000742	0.00287	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000707	0.00274	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.00069	0.00268	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000686	0.00266	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000674	0.00261	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—DGKH—nephrolithiasis	0.000663	0.00257	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000663	0.00257	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000646	0.0025	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000646	0.0025	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—PTH—nephrolithiasis	0.000627	0.00243	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000617	0.00239	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.00061	0.00236	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000602	0.00233	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000602	0.00233	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—DGKH—nephrolithiasis	0.00056	0.00217	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00056	0.00217	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.00055	0.00213	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000546	0.00212	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PTH—nephrolithiasis	0.0005	0.00194	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000479	0.00186	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000467	0.00181	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000467	0.00181	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000461	0.00178	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000438	0.0017	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PTH—nephrolithiasis	0.000438	0.0017	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000429	0.00166	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000417	0.00161	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000405	0.00157	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000391	0.00151	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000388	0.0015	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PTH—nephrolithiasis	0.00037	0.00144	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000333	0.00129	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000332	0.00129	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000332	0.00129	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000301	0.00117	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000287	0.00111	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000255	0.00099	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000251	0.000972	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000237	0.000917	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—SPP1—nephrolithiasis	0.00022	0.000852	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000217	0.000842	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000217	0.000842	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000214	0.00083	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000186	0.00072	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000155	0.0006	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00014	0.000542	CbGpPWpGaD
